Recombinant Human Papillomavirus Type 11 L1 Protein Uses, Dosage, Side Effects and more
Recombinant Human Papillomavirus Type 11 L1 Protein is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) types 6, 11, 16 and 18.The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, and 18, which are produced by separate fermentations in recombinant Saccharomyces cerevisiae and self-assembled into VLPs.
| Trade Name | Recombinant Human Papillomavirus Type 11 L1 Protein |
| Generic | Human papillomavirus type 11 L1 capsid protein antigen |
| Human papillomavirus type 11 L1 capsid protein antigen Other Names | L1 protein, Human papillomavirus type 11 Vaccine, Recombinant human papillomavirus type 11 L1 protein |
| Type | |
| Groups | Approved |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
